The medication regimen begins at 3 mg daily for the first 30 days, escalates to 7 mg for the next 30 days, and then moves to the target maintenance dose of 14 mg
Survodutide from Boehringer Ingelheim is a dual GLP-1/glucagon receptor agonist, a different dual-agonist approach than tirzepatide
This combination therapy could offer a more comprehensive weight management approach, addressing fat loss and muscle preservation
doi: 10.1126/science.aaf6463 120 Marshall-PhelpsK
It should only be used under the supervision of a licensed provider
Options to consider include: Walking, starting with whatever distance feels comfortable Swimming or water-based exercise, where the water supports your body weight Stationary cycling at a gentle pace Yoga or Pilates, which combine movement with breathing and balance Tai chi is particularly helpful for joint stiffness and balance Resistance training for muscle and bone Resistance training can help to manage lupus for two reasons